Correlation Between Biotechnology Ultrasector and Growth Strategy

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Growth Strategy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Growth Strategy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Growth Strategy Fund, you can compare the effects of market volatilities on Biotechnology Ultrasector and Growth Strategy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Growth Strategy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Growth Strategy.

Diversification Opportunities for Biotechnology Ultrasector and Growth Strategy

0.03

Correlation Coefficient

Biotechnology Ultrasector  Growth Strategy

Significant diversification

The 3 months correlation between Biotechnology and Growth is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Growth Strategy Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Growth Strategy and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Growth Strategy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Growth Strategy has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Growth Strategy go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Growth Strategy

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Growth Strategy. In addition to that, Biotechnology Ultrasector is 4.2 times more volatile than Growth Strategy Fund. It trades about -0.05 of its total potential returns per unit of risk. Growth Strategy Fund is currently generating about 0.12 per unit of volatility. If you would invest  1,299  in Growth Strategy Fund on September 13, 2024 and sell it today you would earn a total of  47.00  from holding Growth Strategy Fund or generate 3.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Growth Strategy Fund

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Growth Strategy

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Growth Strategy Fund are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Growth Strategy is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Ultrasector and Growth Strategy

The main advantage of trading using opposite Biotechnology Ultrasector and Growth Strategy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Growth Strategy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Growth Strategy will offset losses from the drop in Growth Strategy's long position.

The idea behind Biotechnology Ultrasector Profund and Growth Strategy Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.